Drug Search Results
More Filters [+]

Dropropizine

Alternative Names: dropropizine
Latest Update: 2022-09-19
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Czech | Dominican Republic | Italy | Mexico | Portugal | Slovakia

Approved Indications: None

Known Adverse Events: None

Company: Ache Labs
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dropropizine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Inflammation|Rhinitis|Common Cold

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ACH-NTS-03(02/10)

P3

Withdrawn

Common Cold|Inflammation|Rhinitis

2012-04-01

Recent News Events